ReceptivaDx

ReceptivaDx is an innovative brand dedicated to addressing the complexities of infertility, particularly through their groundbreaking test for endometriosis—a key contributor to unexplained infertility. This first-of-its-kind diagnostic tool assesses multiple factors in a single sample, including the BCL6 marker for uterine lining inflammation and risks associated with progesterone resistance. ReceptivaDx empowers women and families by providing much-needed insights for those struggling with failed IVF or recurrent pregnancy loss, shedding light on conditions like endometriosis and endometritis.

The company’s commitment to improving outcomes is reflected in numerous success stories from patients who have conceived following treatment guided by their test results. In addition to cutting-edge diagnostics, ReceptivaDx offers comprehensive support, including free consultations and access to healthcare professionals. By fostering understanding and treatment for unexplained infertility, ReceptivaDx aims to restore hope and increase the chances of successful pregnancies for women everywhere